Minhua Chen
61Patents
3h-index
36Co-inventors
62Inventor score
Filing activity: Sep 21, 2010 → Feb 3, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10246418B2 | Crystal form of lenvatinib methanesulfonate salt and preparation method thereof | Chemistry; Metallurgy | 5 | Active |
| US9994579B2 | Salt of pyrrolo[2,3-D]pyrimidine compound and novel polymorph of salt | Chemistry; Metallurgy | 3 | Active |
| US10703724B2 | Crystalline forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl] amino} acetic acid and processes for preparation thereof | Chemistry; Metallurgy | 3 | Active |
| USD999901S1 | Fan blade | General | 2 | Active |
| USD993384S1 | Fan | General | 2 | Active |
| USD1038203S1 | Magnifying glass with light | General | 2 | Active |
| US9751889B2 | Crystalline form I of ibrutinib | Chemistry; Metallurgy | 2 | Active |
| US11117871B2 | Crystalline forms of GSK1278863, preparation method and pharmaceutical use thereof | Chemistry; Metallurgy | 1 | Active |
| US11028060B2 | Crystalline forms of ozanimod and processes for preparation thereof | Chemistry; Metallurgy | 1 | Active |
| US10882830B2 | Crystal form of ozanimod hydrochloride and processes for preparation therefor | Chemistry; Metallurgy | 1 | Active |
| US9957240B2 | Crystalline forms of trisodium supramolecular complex comprising valsartan and AHU-377 and methods thereof | Chemistry; Metallurgy | 1 | Active |
| US10323035B2 | Co-crystal of a CDK inhibitor and an MEK inhibitor and process of preparation thereof | Chemistry; Metallurgy | 1 | Active |
| USD1038202S1 | Magnifying glass with light | General | 1 | Active |
| US10577334B2 | Crystalline form E of tafamidis meglumine, process for preparation and use thereof | Chemistry; Metallurgy | 1 | Active |
| US10604528B2 | Galunisertib crystalline form, preparation method thereof and use thereof | Chemistry; Metallurgy | 1 | Active |
| US11111223B2 | Crystalline forms of ozanimod and ozanimod hydrochloride, and processes for preparation thereof | Chemistry; Metallurgy | 1 | Active |
| US11117876B2 | Crystalline form of ozanimod hydrochloride, and processes for preparation thereof | Chemistry; Metallurgy | 1 | Active |
| US9969701B2 | Salts and co-crystals of lesinurad | Chemistry; Metallurgy | 1 | Active |
| US10351536B2 | Crystalline forms of lesinurad and its sodium salt | Chemistry; Metallurgy | 0 | Active |
| US12049463B2 | Crystalline form of Tolebrutinib | Chemistry; Metallurgy | 0 | Active |
| US11136347B2 | Crystalline forms of a fatty acid bile acid conjugate, preparation method thereof and use thereof | Chemistry; Metallurgy | 0 | Active |
| US11124517B2 | Crystal form of Baricitinib and preparation method thereof | Chemistry; Metallurgy | 0 | Active |
| US11149004B2 | Crystalline form of EB-1020, processes for preparation and use thereof | Chemistry; Metallurgy | 0 | Active |
| US11827630B2 | Crystal form of lanifibranor, preparation method therefor, and use thereof | Chemistry; Metallurgy | 0 | Active |
| US11680050B2 | Crystalline forms of ozanimod and ozanimod hydrochloride, and processes for preparation thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.